Study of the Relative Abuse Potential of Acurox Tablets in Non-Dependent Recreational Opioid Users

NCT01030406 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Opioid Abuse

Interventions

DRUG: 40/0mg taken first
DRUG: 80/0mg taken first
DRUG: 40/240mg taken first
DRUG: 80/480mg taken first
DRUG: 0/0mg taken first

Sponsor

Acura Pharmaceuticals Inc.

Collaborators

[object Object]